Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Humana ...

Humana Inc. HUM is set to report second-quarter 2026 results on July 29, before the opening bell. The Zacks Consensus ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

Health insurer Humana has named healthcare industry veteran Jim Rechtin as its president and chief operating officer, effective January 8, 2024, as part of a long-planned CEO transition. He will ...

Humana (NYSE: HUM) currently trades around $355 per share, nearly 30% below its peak level of $495 seen in September 2022. In comparison, UnitedHealth stock (NYSE: UNH) saw its stock rise 13% over the ...

Humana stock rises as Wells Fargo upgrades to Overweight, lifts target to $502 on easing Medicare Advantage costs.

Humana Inc. (NYSE HUM) and USAA Life Insurance Company (USAA Life) today reaffirm their shared commitment to veterans’ well-being with the continuation of co-branded Medicare Advantage plans for 2026 ...

Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability ...

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. This voice experience is generated by AI. Learn more. This voice ...